COVID-19 Impact on Global Immuno-Oncology Treatment Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Immuno-Oncology Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immuno-Oncology Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Monoclonal Antibodies
1.4.4 Cytokine-Based Immunotherapy
1.4.5 Cancer Vaccines
1.4.6 CAR-T Cell Therapy
1.5 Market by Application
1.5.1 Global Immuno-Oncology Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Center
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Immuno-Oncology Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Immuno-Oncology Treatment Industry
1.6.1.1 Immuno-Oncology Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Immuno-Oncology Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Immuno-Oncology Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Immuno-Oncology Treatment Market Perspective (2015-2026)
2.2 Immuno-Oncology Treatment Growth Trends by Regions
2.2.1 Immuno-Oncology Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immuno-Oncology Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Immuno-Oncology Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Immuno-Oncology Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Immuno-Oncology Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Treatment Players by Market Size
3.1.1 Global Top Immuno-Oncology Treatment Players by Revenue (2015-2020)
3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immuno-Oncology Treatment Market Concentration Ratio
3.2.1 Global Immuno-Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Treatment Revenue in 2019
3.3 Immuno-Oncology Treatment Key Players Head office and Area Served
3.4 Key Players Immuno-Oncology Treatment Product Solution and Service
3.5 Date of Enter into Immuno-Oncology Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2015-2020)
4.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2021-2026)
5 Immuno-Oncology Treatment Breakdown Data by Application (2015-2026)
5.1 Global Immuno-Oncology Treatment Market Size by Application (2015-2020)
5.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immuno-Oncology Treatment Market Size (2015-2020)
6.2 Immuno-Oncology Treatment Key Players in North America (2019-2020)
6.3 North America Immuno-Oncology Treatment Market Size by Type (2015-2020)
6.4 North America Immuno-Oncology Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immuno-Oncology Treatment Market Size (2015-2020)
7.2 Immuno-Oncology Treatment Key Players in Europe (2019-2020)
7.3 Europe Immuno-Oncology Treatment Market Size by Type (2015-2020)
7.4 Europe Immuno-Oncology Treatment Market Size by Application (2015-2020)
8 China
8.1 China Immuno-Oncology Treatment Market Size (2015-2020)
8.2 Immuno-Oncology Treatment Key Players in China (2019-2020)
8.3 China Immuno-Oncology Treatment Market Size by Type (2015-2020)
8.4 China Immuno-Oncology Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immuno-Oncology Treatment Market Size (2015-2020)
9.2 Immuno-Oncology Treatment Key Players in Japan (2019-2020)
9.3 Japan Immuno-Oncology Treatment Market Size by Type (2015-2020)
9.4 Japan Immuno-Oncology Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Immuno-Oncology Treatment Market Size (2015-2020)
10.2 Immuno-Oncology Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immuno-Oncology Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Immuno-Oncology Treatment Market Size by Application (2015-2020)
11 India
11.1 India Immuno-Oncology Treatment Market Size (2015-2020)
11.2 Immuno-Oncology Treatment Key Players in India (2019-2020)
11.3 India Immuno-Oncology Treatment Market Size by Type (2015-2020)
11.4 India Immuno-Oncology Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immuno-Oncology Treatment Market Size (2015-2020)
12.2 Immuno-Oncology Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Immuno-Oncology Treatment Market Size by Type (2015-2020)
12.4 Central & South America Immuno-Oncology Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview and Its Total Revenue
13.1.3 Amgen Immuno-Oncology Treatment Introduction
13.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca Immuno-Oncology Treatment Introduction
13.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction
13.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Eli-Lilly
13.4.1 Eli-Lilly Company Details
13.4.2 Eli-Lilly Business Overview and Its Total Revenue
13.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction
13.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.4.5 Eli-Lilly Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Immuno-Oncology Treatment Introduction
13.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.5.5 Roche Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction
13.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Janssen Biotech
13.7.1 Janssen Biotech Company Details
13.7.2 Janssen Biotech Business Overview and Its Total Revenue
13.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction
13.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.7.5 Janssen Biotech Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview and Its Total Revenue
13.8.3 Merck Immuno-Oncology Treatment Introduction
13.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview and Its Total Revenue
13.9.3 Novartis Immuno-Oncology Treatment Introduction
13.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview and Its Total Revenue
13.10.3 Pfizer Immuno-Oncology Treatment Introduction
13.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2015-2020)
13.10.5 Pfizer Recent Development
13.11 Sanofi
10.11.1 Sanofi Company Details
10.11.2 Sanofi Business Overview and Its Total Revenue
10.11.3 Sanofi Immuno-Oncology Treatment Introduction
10.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2015-2020)
10.11.5 Sanofi Recent Development
13.12 Spectrum Pharmaceuticals
10.12.1 Spectrum Pharmaceuticals Company Details
10.12.2 Spectrum Pharmaceuticals Business Overview and Its Total Revenue
10.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction
10.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2015-2020)
10.12.5 Spectrum Pharmaceuticals Recent Development
13.13 Takeda
10.13.1 Takeda Company Details
10.13.2 Takeda Business Overview and Its Total Revenue
10.13.3 Takeda Immuno-Oncology Treatment Introduction
10.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2015-2020)
10.13.5 Takeda Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Immuno-Oncology Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Immuno-Oncology Treatment Revenue
Table 3. Ranking of Global Top Immuno-Oncology Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immuno-Oncology Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immune Checkpoint Inhibitors
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Cytokine-Based Immunotherapy
Table 8. Key Players of Cancer Vaccines
Table 9. Key Players of CAR-T Cell Therapy
Table 10. COVID-19 Impact Global Market: (Four Immuno-Oncology Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Immuno-Oncology Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Immuno-Oncology Treatment Players to Combat Covid-19 Impact
Table 15. Global Immuno-Oncology Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Immuno-Oncology Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Immuno-Oncology Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Immuno-Oncology Treatment Market Share by Regions (2015-2020)
Table 19. Global Immuno-Oncology Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Immuno-Oncology Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Immuno-Oncology Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Immuno-Oncology Treatment Players
Table 26. Global Immuno-Oncology Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Immuno-Oncology Treatment Market Share by Players (2015-2020)
Table 28. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology Treatment as of 2019)
Table 29. Global Immuno-Oncology Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Immuno-Oncology Treatment Product Solution and Service
Table 32. Date of Enter into Immuno-Oncology Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Immuno-Oncology Treatment Market Size Share by Type (2015-2020)
Table 36. Global Immuno-Oncology Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Immuno-Oncology Treatment Market Size Share by Application (2015-2020)
Table 38. Global Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Immuno-Oncology Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Immuno-Oncology Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Immuno-Oncology Treatment Market Share (2019-2020)
Table 42. North America Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Immuno-Oncology Treatment Market Share by Type (2015-2020)
Table 44. North America Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Immuno-Oncology Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Immuno-Oncology Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Immuno-Oncology Treatment Market Share (2019-2020)
Table 48. Europe Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Immuno-Oncology Treatment Market Share by Type (2015-2020)
Table 50. Europe Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Immuno-Oncology Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Immuno-Oncology Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Immuno-Oncology Treatment Market Share (2019-2020)
Table 54. China Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Immuno-Oncology Treatment Market Share by Type (2015-2020)
Table 56. China Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Immuno-Oncology Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Immuno-Oncology Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Immuno-Oncology Treatment Market Share (2019-2020)
Table 60. Japan Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Immuno-Oncology Treatment Market Share by Type (2015-2020)
Table 62. Japan Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Immuno-Oncology Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Immuno-Oncology Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Immuno-Oncology Treatment Market Share (2019-2020)
Table 66. Southeast Asia Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Immuno-Oncology Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Immuno-Oncology Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Immuno-Oncology Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Immuno-Oncology Treatment Market Share (2019-2020)
Table 72. India Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Immuno-Oncology Treatment Market Share by Type (2015-2020)
Table 74. India Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Immuno-Oncology Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Immuno-Oncology Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Immuno-Oncology Treatment Market Share (2019-2020)
Table 78. Central & South America Immuno-Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Immuno-Oncology Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Immuno-Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Immuno-Oncology Treatment Market Share by Application (2015-2020)
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Product
Table 85. Amgen Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 86. Amgen Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Product
Table 90. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 91. AstraZeneca Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Product
Table 95. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Eli-Lilly Company Details
Table 98. Eli-Lilly Business Overview
Table 99. Eli-Lilly Product
Table 100. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 101. Eli-Lilly Recent Development
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Product
Table 105. Roche Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 106. Roche Recent Development
Table 107. GlaxoSmithKline Company Details
Table 108. GlaxoSmithKline Business Overview
Table 109. GlaxoSmithKline Product
Table 110. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 111. GlaxoSmithKline Recent Development
Table 112. Janssen Biotech Company Details
Table 113. Janssen Biotech Business Overview
Table 114. Janssen Biotech Product
Table 115. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 116. Janssen Biotech Recent Development
Table 117. Merck Business Overview
Table 118. Merck Product
Table 119. Merck Company Details
Table 120. Merck Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 121. Merck Recent Development
Table 122. Novartis Company Details
Table 123. Novartis Business Overview
Table 124. Novartis Product
Table 125. Novartis Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 126. Novartis Recent Development
Table 127. Pfizer Company Details
Table 128. Pfizer Business Overview
Table 129. Pfizer Product
Table 130. Pfizer Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 131. Pfizer Recent Development
Table 132. Sanofi Company Details
Table 133. Sanofi Business Overview
Table 134. Sanofi Product
Table 135. Sanofi Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 136. Sanofi Recent Development
Table 137. Spectrum Pharmaceuticals Company Details
Table 138. Spectrum Pharmaceuticals Business Overview
Table 139. Spectrum Pharmaceuticals Product
Table 140. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 141. Spectrum Pharmaceuticals Recent Development
Table 142. Takeda Company Details
Table 143. Takeda Business Overview
Table 144. Takeda Product
Table 145. Takeda Revenue in Immuno-Oncology Treatment Business (2015-2020) (Million US$)
Table 146. Takeda Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immune Checkpoint Inhibitors Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Cytokine-Based Immunotherapy Features
Figure 5. Cancer Vaccines Features
Figure 6. CAR-T Cell Therapy Features
Figure 7. Global Immuno-Oncology Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Center Case Studies
Figure 10. Others Case Studies
Figure 11. Immuno-Oncology Treatment Report Years Considered
Figure 12. Global Immuno-Oncology Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Immuno-Oncology Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Immuno-Oncology Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Immuno-Oncology Treatment Market Share by Players in 2019
Figure 17. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-Oncology Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2019
Figure 19. North America Immuno-Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Immuno-Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Immuno-Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Immuno-Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Immuno-Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Immuno-Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Immuno-Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 28. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 30. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 32. Eli-Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 34. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 36. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 38. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 40. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 42. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 44. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 46. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 48. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 50. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs